Allworth Financial’s Ginkgo Bioworks DNA Stock Holding History

Allworth Financial’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.25K	Buy	731 +270	+59%	+$2.26K	﹤0.01%	3925
2026 Q1	$2.83K	Buy	461 +432	+1,490%	+$3.59K	﹤0.01%	4229
2025 Q4	$241	Buy	29 +10	+53%	+$108	﹤0.01%	4680
2025 Q3	$278	Buy	19 +3	+19%	+$36	﹤0.01%	4557
2025 Q2	$180	Buy	16 +2	+14%	+$15	﹤0.01%	4333
2025 Q1	$111	Buy	14 +7	+100%	+$71	﹤0.01%	3947
2024 Q4	$91	Hold	7	–	–	﹤0.01%	3847
2024 Q3	$58	Sell	7 -2	-22%	-$20	﹤0.01%	3679
2024 Q2	$101	Buy	9 +6	+200%	+$179	﹤0.01%	3597
2024 Q1	$116	Hold	3	–	–	﹤0.01%	3500
2023 Q4	$169	Sell	3 -1	-25%	-$61	﹤0.01%	3303
2023 Q3	$305	Buy	4 +1	+33%	+$80	﹤0.01%	3165
2023 Q2	$186	Hold	3	–	–	﹤0.01%	3114
2023 Q1	$133	Buy	+3	New	+$190	﹤0.01%	3075
2022 Q4	–	Sell	-104	Closed	-$13K	–	3055
2022 Q3	$13K	Buy	+104	New	+$12.4K	﹤0.01%	1471

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Allworth Financial's DNA Position: Q2 2026 in Review

Allworth Financial increased its Ginkgo Bioworks (DNA) stake by 59% in Q2 2026, buying an estimated $2.26K and bringing the position to 731 shares worth $7.25K. The position accounts for ﹤0.01% of the portfolio, ranked #3925.

Allworth Financial first reported a position in DNA in Q3 2022 and has held it in 15 quarters since. The position peaked at $13K in Q3 2022. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Allworth Financial held 731 shares of Ginkgo Bioworks worth $7.25K as of Q2 2026.
Allworth Financial bought 270 Ginkgo Bioworks shares in Q2 2026, an estimated $2.26K.
Ginkgo Bioworks made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3925 holding.
Allworth Financial first reported a position in Ginkgo Bioworks in Q3 2022 and has held it in 15 quarters since.
Allworth Financial's Ginkgo Bioworks position peaked at $13K in Q3 2022.
183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.